SAVANNAH KING: Open Payments
NPI 1437614120 · LEBANON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,203 in 81 payments from 14 companies in 2025. Trend: 2023 $1,076 · 2024 $1,398 · 2025 $1,203
Food & beverage: $1,203
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $202 |
| Amgen Inc. | 23 | $200 |
| Merck Sharp & Dohme LLC | 10 | $165 |
| Novo Nordisk Inc | 5 | $148 |
| E.R. Squibb & Sons, L.L.C. | 10 | $147 |
| AstraZeneca Pharmaceuticals LP | 6 | $94 |
| SCPHARMACEUTICALS INC. | 2 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| ABIOMED | 1 | $33 |
| Alnylam Pharmaceuticals Inc. | 2 | $30 |
Products named: REPATHA, LEQVIO, VERQUVO, CAMZYOS, Wegovy, FARXIGA, FUROSCIX, Kerendia.
Industry payments across KY — which companies pay providers there.
